Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-24-003742

Chief Executive Officer sold 29,202 shares at an average $0.85 ($24,734)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rawcliffe Adrian Chief Executive Officer 2024-01-11 Sale −11,945 $0.84 $9,994 18,395 D
Rawcliffe Adrian Chief Executive Officer 2024-01-12 Sale −17,257 $0.85 $14,739 26,388 D
Open-market sales · 29,202 sh · avg $0.85 · $24,734
Loading xslF345X05/tm243270-1_4seq1.xml…